What is Tecfidera?
Dimethyl fumarate (Tecfidera) is an oral drug widely used to treat multiple sclerosis (Multiple Sclerosis, MS). Multiple sclerosis is an autoimmune disease characterized by an attack of the immune system on the central nervous system, resulting in demyelination of neurons and impairment of neurological function.
The main ingredient of Tecfidera is dimethyl fumarate, a compound with immunomodulatory effects. Its mechanism of action mainly involves the impact on the immune system, by slowing down the inflammatory response and inhibiting the activity of immune cells, thereby reducing damage to the central nervous system. The drug is expected to slow the progression of multiple sclerosis and improve patients' quality of life while regulating the balance of the immune system.
One of the features of Tecfidera is its oral administration form, which provides patients with a more convenient treatment option compared to injectable drugs. Patients typically require oral administration twice daily, making administration of the drug more flexible and easier to implement. This has positive significance for improving patient compliance and reducing the burden of treatment.
However, like all medications, Tecfidera may be associated with some side effects, including but not limited to gastrointestinal discomfort, decreased blood cell counts, etc. Therefore, during the use of Tecfidera, patients should pay close attention to any potential adverse reactions and maintain good communication with medical professionals in order to adjust the treatment plan in a timely manner. Overall, Tecfidera plays an active role in the treatment of multiple sclerosis, providing patients with an effective and convenient treatment option.
The original drug of dimethyl fumarate has been launched in China and has been included in medical insurance. Patients can buy it domestically at a price of about 5,000 to 6,000 yuan. Please consult the local hospital pharmacy for specific prices. The main foreign drug is dimethyl fumarate original drug. The cheaper one is the Indian original drug, which costs more than 2,000 yuan and has the same composition and efficacy as the domestic original drug.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)